OpenVSafe by OpenVAERS
Search V-safe

QNM-26926-45681

3 vaccinations 2 coded responses 14 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
019 / MA
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-06
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-08
    Registered in v-safe
  4. 2021-01-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Swollen lymph node
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-08
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lymph node (armpit)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-01-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-01-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-12-02
    Dose 3 — Moderna
  14. 2022-01-06
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-01-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-01-13
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-03-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-06-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-12-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-16Pfizer-BioNTech
22021-01-06Pfizer-BioNTech
32021-12-02Moderna No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-08

Systemic reaction (other): Swollen lymph node

2021-01-09

Systemic reaction (other): Swollen lymph node (armpit)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release